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Abstract 
Background: Cambodia has seen a marked reduction in the incidence of Plasmodium falciparum over the past dec-
ade without a corresponding decline in Plasmodium vivax incidence. It is unknown to what extent local transmission 
is sustained by a chain of clinical and sub-clinical infections or by continued re-introduction via migration. Using an 
ultrasensitive molecular technique, 20 villages in western Cambodia were surveyed to detect the low season preva-
lence of P. falciparum and P. vivax and local treatment records were reviewed.
Methods: During March to May 2015 cross-sectional surveys were conducted in 20 villages in Battambang, western 
Cambodia. Demographic and epidemiological data and venous blood samples were collected from 50 randomly 
selected adult volunteers in each village. Blood was tested for Plasmodium infections by rapid diagnostic test (RDT), 
microscopy and high volume (0.5 ml packed red blood cell) quantitative polymerase chain reaction (uPCR). Positive 
samples were analysed by nested PCR to determine the Plasmodium species. Malaria case records were collected from 
the Provincial Health Department and village malaria workers to determine incidence and migration status.
Results: Among the 1000 participants, 91 (9.1%) were positive for any Plasmodium infection by uPCR, seven (0.7%) by 
microscopy, and two (0.2%) by RDT. uPCR P. vivax prevalence was 6.6%, P. falciparum 0.7%, and undetermined Plasmo-
dium species 1.8%. Being male (adjusted OR 2.0; 95% CI 1.2-3.4); being a young adult <30 years (aOR 2.1; 95% CI 1.3–
3.4); recent forest travel (aOR 2.8; 95% CI 1.6–4.8); and, a history of malaria (aOR 5.2; 95% CI 2.5–10.7) were independent 
risk factors for parasitaemia. Of the clinical malaria cases diagnosed by village malaria workers, 43.9% (297/634) and 
38.4% (201/523) were among migrants in 2013 and in 2014, respectively. Plasmodium vivax prevalence determined by 
uPCR significantly correlated with vivax malaria incidences in both 2014 and 2015 (p = 0.001 and 0.002, respectively), 
whereas no relationship was observed in falciparum malaria (p = 0.36 and p = 0.59, respectively).
Discussion: There was heterogeneity in the malaria parasite reservoir between villages, and Plasmodium prevalence 
correlated with subsequent malaria incidence. The association was attributable chiefly to P. vivax infections, which 
were nine-fold more prevalent than P. falciparum infections. In the absence of a radical cure with 8-aminoquinolines, P. 
vivax transmission will continue even as P. falciparum prevalence declines. Migration was associated with over a third 
of incident cases of clinical malaria.
Trial registration clinicaltrials.gov (NCT01872702). Registered 4 June 2013
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
Malaria Journal
*Correspondence:  Rupam@tropmedres.ac 
†Rupam Tripura and Thomas J. Peto contributed equally to this work 
1 Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical 
Medicine, Mahidol University, 420/6 Rajvithi Rd, Rajthevee, 
Bangkok 10400, Thailand
Full list of author information is available at the end of the article
Page 2 of 12Tripura et al. Malar J  (2017) 16:56 
Background
Malaria incidence in Cambodia has decreased by approx-
imately 42% from 2009 to 2015 [1]. The treatment records 
of the National Malaria Control Programme, which do 
not include the private sector, report that this was driven 
chiefly by a decline of 55% in Plasmodium falciparum, 
whereas Plasmodium vivax declined by only 17%. This 
progress was due to the roll-out of rapid diagnostic tests 
(RDTs), treatment of confirmed malaria cases with arte-
misinin combination therapy (ACT) provided by village 
malaria workers (VMWs), and the distribution of insecti-
cide treated bed-nets (ITNs) [1].
The Thai-Cambodian border area around Pailin Prov-
ince in western Cambodia has been a cradle of anti-malar-
ial drug resistance. In the 1960s, resistance of P. falciparum 
to chloroquine emerged from this area before spread-
ing to Asia and Africa and causing millions of deaths [2]. 
Since 2007 several studies have shown that P. falciparum 
in western Cambodia has become resistant to artemisinins 
and more recently to the partner drugs used in ACT, such 
as piperaquine [3–6]. Subsequently, artemisinin-resistant 
Plasmodium parasites were found on the Thai-Myanmar 
border and other parts of Southeast Asia [7]. ACT offers 
the most effective anti-malarial drugs currently available, 
and the loss of these drugs would be a setback of poten-
tially disastrous proportions for global malaria control and 
for elimination strategies in Southeast Asia [8, 9]. There is 
increasing evidence that in order to prevent the spread of 
artemisinin-resistant P. falciparum it is necessary to com-
pletely interrupt P. falciparum transmission [10–12].
Previous surveys have described an asymptomatic res-
ervoir of malaria in Cambodia [13, 14]. Microscopy and 
RDTs are not sensitive enough to detect the majority of 
sub-clinical Plasmodium infections [13, 15, 16]. High-
volume, ultra-sensitive, quantitative polymerase chain 
reaction (uPCR) is a recently developed method that can 
detect approximately 85% of all sub-clinical Plasmodium 
parasitaemias and thus characterize in detail the micro-
epidemiology of malaria in areas of low transmission. 
These sub-clinical parasitaemias may play an important 
role in the transmission of infection, especially in areas of 
low and seasonal transmission [17, 18].
There are large seasonal population movements in and 
out of Samlout District in Battambang Province where 
the study was conducted. People from the district, pre-
dominantly men, spend time working outside the dis-
trict and some return infected with malaria parasites. 
Agricultural labourers from other provinces come into 
the district to work during harvests and may harbour 
sub-clinical malaria infections acquired in other parts 
of the country. Seasonal work in forests collecting fruit, 
vines and hunting small game puts local people at risk of 
infection. These may contribute disproportionately to the 
transmission of malaria parasites. Battambang Provin-
cial Health Department reports that approximately 83% 
of all malaria cases were aged 15–49 years, and 82% were 
males in 2014. The proportion of malaria cases among 
migrant workers in Battambang increased from 19% in 
2009 to around 40% in 2014. In Cambodian border areas, 
the role of local, national and international migrants in 
malaria transmission has been acknowledged; however, 
the attributable fraction of infections has not been deter-
mined [19]. Outdoor and forest-acquired malaria infec-
tions continue to be important sources of transmission 
despite high rates of deforestation in the border areas of 
Cambodia.
Accurate malaria risk stratification is important for tar-
geting control and elimination activities. Following the 
decline in P. falciparum infections over the past decade 
in western Cambodia, it is unknown to what extent local 
transmission is sustained by a chain of clinical infections, 
a reservoir of sub-microscopic malaria, or by continued 
introduction via migration. 20 villages in western Cam-
bodia were surveyed to detect the sub-clinical prevalence 
of Plasmodium infections in an area where transmission 
is low but persistent and analysed the data with reference 
to available treatment records.
Methods
Study site
During the low season of malaria in March to May 2015, 
cross-sectional surveys were conducted in 20 villages in 
Samlout District, Battambang Province, western Cam-
bodia. All available VMW records and provincial malaria 
data were reviewed. Samlout District lies to the south of 
Pailin Province, north of Pursat Province and the Carda-
mom Mountains, and east of Thailand (Fig. 1). Samlout 
is primarily an agricultural district with forested areas 
along the border. Samlout was chosen for this study 
as it has villages with some of the highest incidence of 
clinical malaria in Battambang Province and seasonal 
transmission.
Selection of villages and participants
Within Samlout District, 18 villages with the high-
est malaria incidence in 2014 were selected along with 
Keywords: Malaria, Plasmodium Falciparum, Plasmodium vivax, Asymptomatic, Sub-clinical, Sub-microscopic, uPCR, 
Cambodia
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two neighbouring villages, totalling 20. A census based 
on pre-existing village population lists was updated 
and household lists were prepared. Surveyed house-
holds were selected using randomization methods from 
the list to ensure that every household had an equal 
chance of being selected. A stratified sampling method 
obtained approximately equal samples of adults aged 
18 years or over from four groups (male/female, under/
over 30 years). Unless the total number of households in 
a village was fewer than 50, no more than one person per 
household was selected. For the villages with fewer than 
50 households, more than one participant was randomly 
selected from the list. In cases of refusal or a person 
being absent on the survey day, replacement partici-
pants were selected randomly from the same household 
or the next household on the list. Pregnant women were 
excluded from the randomization as they would be ineli-
gible to join a mass anti-malarial treatment study which 
followed this survey.
Community engagement and informed consent
Public meetings were conducted in Khmer by a dedicated 
Community Engagement Team (CE-Team) to inform the 
commune authorities, VMWs and village leaders about 
the study. All residents were invited to a meeting prior to 
the survey where the consent form was read aloud and 
questions were answered. Individual written informed 
consent was obtained immediately prior to sample col-
lection and interview. A fingerprint was obtained from 
participants who could not read and write and a witness 
countersigned their consent form.
Survey methods
Anthropometric and demographic data were collected, 
including tympanic temperature, height, weight, health 
status, malaria history, bed net use, travel history, and 
occupation; 1.5  ml of venous blood was collected in an 
EDTA tube. Samples were kept in a cool box and sent 
to a nearby hospital laboratory on the same day. If a 
Fig. 1 Plasmodium species determined by quantitative PCR in twenty villages in Battambang Province in 2015. Villageswere selected for the survey 
according to their high malaria incidence in 2013–2014 from provincial malaria records; or, for villages with no village malaria worker, on the advice 
of local health centres which received referred malaria patients
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participant was febrile (defined as tympanic tempera-
ture ≥37.5 C°) an RDT (SD BIOLINE Malaria Ag P.f/P.v, 
Standard Diagnostics, Inc, Gyeonggi-do, Republic of 
Korea) was performed immediately, and if positive, treat-
ment was provided by the VMW according to national 
guidelines.
Laboratory methods
The samples were separated; 200 µl of whole blood was 
used to prepare a dried blood spot on filter paper, a 
blood smear for microscopy, and to perform haemo-
globin assay (HemoCue® Hb 201+Analyzer SE-262 71 
Angeltholm, Sweden). Blood was tested for malaria by 
RDT and microscopy (asexual parasites/500 white blood 
cells (WBCs)). The remaining blood was centrifuged and 
plasma, buffy coat and 500  µl of packed red blood cells 
(pRBCs) for uPCR were separated into three different 
cryo-tubes and stored at −80  °C. Ten per cent negative 
controls of total participant samples were added for each 
village. All the samples were transported to the Mahidol 
University Faculty of Tropical Medicine molecular labo-
ratory in Bangkok.
Molecular laboratory procedures
A detailed description, evaluation and validation of the 
high-volume ultrasensitive (uPCR) methodology has 
been reported previously [15]. In brief, batches of 500 µl 
of pRBCs were thawed and the DNA template, for detec-
tion and quantification of Plasmodium by PCR, was 
extracted and purified. An ultrasensitive quantitative 
real-time PCR method was used to detect the presence of 
malaria parasites and to estimate the numbers (genomes) 
of parasite per millilitre from each sample. The 18S 
rRNA-targeting primers and hydrolysis probes used in 
the assay have been validated and are highly specific for 
Plasmodium species. The lower limit of accurate quanti-
tation of this method is 22 parasites/ml of whole blood 
[15].
A Quanti-Tect Multiplex PCR No ROX® (QIAGEN, 
Hilden, Germany) was used, and the PCR mixture 
and the cycling conditions were as per manufacturer’s 
instructions. For samples containing parasite DNA 
by uPCR analysis, Plasmodium species detection was 
attempted using real time PCR protocols specific to 
18sRNA of P. falciparum and P. vivax. Samples for which 
Plasmodium species were not determined were reported 
as ‘unknown species’.
To detect polymorphisms associated with reduced sus-
ceptibility to artemisinin derivatives the open-reading 
frame of the PF3D7_1343700 kelch propeller domain 
was amplified using a nested PCR protocol [7]. Purified 
PCR products were sequenced at Macrogen, Repub-
lic of Korea and analysed using BioEdit version 7.1.3.0., 
using the 3D7 kelch13 sequence as reference (Accession: 
XM_001350122.1).
Statistical analysis and data management
Data were collected on case record forms and entered on 
smartphones before being exported into Open Clinica. 
Survey data were analysed by univariate and multivariate 
methods to identify risk factors for parasitaemia. Odds 
ratios with 95% confidence intervals were calculated to 
explore which variables were independently associated 
with subclinical infection. The Pearson Chi squared test 
was used to test for the significance of associations. Vari-
ables that were independently associated with sub-clini-
cal parasitaemia at the level of p < 0.05 were explored by 
logistic regression to produce adjusted odds ratios. Inci-
dence rate was calculated by dividing total malaria cases 
in a given year with the total village population and mul-
tiplied by 1,000. Malaria incidence and prevalence were 
compared by linear regression. The analysis was done in 
STATA 14.0 (Timberlake, USA).
Additional data sources and clinical malaria incidence
Malaria case reports were obtained from the Provincial 
Health Department and VMW records. Available treat-
ment records were reviewed by cross-checking with the 
VMWs to confirm the identity of patients. The incidence 
of clinical malaria for 2014 and 2015 was compared to 
the prevalence of malaria parasites detected by uPCR 
in March and April 2015 for each village. Villages with 
no Health Department records were excluded from this 
comparison. For villages where only a hamlet (Chakriya: 
CKA, Samlaut: SLT, Kompoung Tuk A: KTA and Kom-
poung Tuk B: KTB) was selected for the prevalence sur-
vey, the incidence rate of the whole village population 
was used for the analyses. All prevalence survey partici-
pants were from registered households and were consid-
ered to be residents.
Results
Description of the study population
Population size and malaria incidence in 2014-2015 dif-
fered significantly among the 20 study villages. Popula-
tion size ranged from 147 (in Ou Nounong: ONG) to 1012 
(in Ouda: ODA). Malaria incidence per thousand ranged 
between two and 224 among villages in 2014 and 2-166 in 
2015. Two villages (CKA, Miko: MKO) in 2014 and two 
villages (CKA, Peam: PEM) in 2015 were not listed in Pro-
vincial Health Department records, so no incidence data 
were available for these villages (Table 1). The median age 
of the study participants was 33 years (range from 18 to 
78 years). The median age of male and female participants 
were 34 years (18–72 years) and 32.5 years (17–78 years), 
respectively; 11.7% (117/1000) subjects had a temperature 
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of 37.5  °C or higher; 65.4% (654/1000) had a history of 
malaria at any time prior to the survey.
Prevalence of Plasmodium species by detection method
Among 1000 participants, 91 (9.1%) were positive for any 
Plasmodium species by uPCR, seven (0.7%) by micros-
copy, and two (0.2%) by RDT. By uPCR, P. vivax preva-
lence was 6.6% (66/1000), P. falciparum 0.7% (7/1000), 
and 1.8% (18/1000) had undetermined Plasmodium spe-
cies. In Table 1 the parasite prevalence by uPCR is shown 
for each village.
The prevalence in the villages ranged from 0 to 30% by 
uPCR (test for heterogeneity p < 0.001). Plasmodium fal-
ciparum parasites were detected by uPCR in four of the 
20 villages, with P. falciparum prevalence ranging from 
2 to 6% (p =  0.010). Plasmodium vivax infections were 
detected by uPCR in 16 villages, with P. vivax prevalence 
ranging between 2 and 26%, (p < 0.0001) and the unde-
termined Plasmodium species were detected in nine vil-
lages, prevalence ranging from 2 to 10% (p =  0.011 for 
heterogeneity). Three out of 20 villages with had no para-
site prevalence by uPCR.
Factors associated with Plasmodium species positivity 
by uPCR
Factors associated with any positive Plasmodium spe-
cies by uPCR are shown in Table 2. Plasmodium species 
prevalence among males was 14.1% (66/402) versus 4.7% 
(25/532) among females p < 0.001; 11.5% (51/443) among 
those aged 18-29 versus 7.2% (40/557) among those aged 
30 or above p = 0.018. Plasmodium prevalence was 6.8% 
(8/117) among those with temperature of 37.5  °C or 
higher versus 9.3% (83/883) among those with a tempera-
ture below 37.5 °C (p = 0.365). Among participants with 
previous history of clinical malaria, 12.5% (82/654) were 
parasitaemic versus 2.6% (9/346) among those who said 
they had never had malaria (p < 0.0001).
Prevalence of Plasmodium parasites among partici-
pants spending one or more nights in a forest within the 
same period was 22.4% (35/156) versus 6.6% (56/844) 
among those without any forest travel (p < 0.001). Among 
participants with parasitaemia, 27/91 (29.7%) had 
recently stayed overnight in the forest in the same prov-
ince, and 8/91 (8.8%) had stayed in a forest in a different 
province; 56/91 (62%) did not have a history of overnight 
Table 1 Plasmodium species prevalence by uPCR in 2015 cross-sectional surveys and malaria incidence from 2014-15
Incidence total malaria cases/total village population* 1000
Prevalence total Plasmodium species detected by uPCR/total number of test* 100
a Positive for Plasmodium by high-volume qPCR, but the parasite genome count was too low for subsequent nested PCR to determine Plasmodium species
Village code uPCR prevalence Clinical cases from health records
P. falciparum
n/50
(%)
P. vivax
n/50 (%)
aP. species
n/50 (%)
Population 
2014–2015
2014 PF or mix 
cases
(incidence 
per 1000)
2014 All 
malaria cases
(incidence 
per 1000)
2015 Pf or mix 
cases
(incidence 
per 1000)
2015 All malaria 
cases
(incidence 
per 1000)
CKA 0 13 (26) 2 (4) 409 No record No record No record No record
ONG 0 4 (8) 5 (10) 147 7 (47.6) 33 (224.5) 2 (13.6) 12 (81.6)
PTA 1 (2) 5 (10) 2 (4) 283 7 (24.7) 39 (137.8) 0 (0.0) 2 (7.1)
PRY 0 8 (16) 0 614 11 (17.9) 115 (187.3) 44 (71.7) 102 (166.1)
OTG 0 5 (10) 2 (4) 239 10 (41.8) 43 (179.9) 11 (46.0) 26 (108.8)
TTK 0 7 (14) 0 214 1 (4.7) 21 (98.1) 3 (14.0) 7 (32.7)
SLT 0 5 (10) 1 (2) 657 11 (16.7) 43 (65.4) 38 (57.8) 61 (92.8)
CMN 0 6 (12) 0 642 8 (12.5) 17 (26.5) 7 (10.9) 13 (20.2)
PEM 0 4 (8) 2 (4) 257 0.0 1 (3.9) No record No record
OTT 2 (4) 1 (2) 2 (4) 300 0.0 1 (3.3) 2 (6.7) 2 (6.7)
ODA 3 (6) 1 (2) 0 1012 28 (27.7) 35 (34.6) 19 (18.8) 22 (21.7)
OKH 0 2 (4) 1 (2) 631 3 (4.8) 45 (71.3) 15 (23.8) 29 (46.0)
VRM 1 (2) 2 (4) 0 291 28 (96.2) 71 (244.0) 8 (27.5) 28 (96.2)
KTB 0 1 (2) 0 748 5 (6.7) 10 (13.4) 1 (1.3) 3 (4.0)
SRH 0 1 (2) 0 562 3 (5.3) 6 (10.7) 2 (3.6) 3 (5.3)
MKO 0 0 1 (2) 313 No record No record 3 (9.6) 15 (47.9)
OCL 0 1 (2) 0 456 0 (0.0) 1 (2.2) 3 (6.6) 5 (11.0)
CLK 0 0 0 275 3 (10.9) 6 (21.8) 2 (7.3) 3 (10.9)
KTA 0 0 0 748 5 (6.7) 10 (13.4) 1 (1.3) 3 (4.0)
APP 0 0 0 397 0 (0.0) 4 (10.1) 0 (0.0) 1 (2.5)
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stay in the forest (p < 0.001). Parasite prevalence among 
participants with a history of travel outside the village 
within the previous 3 months was 10.2% (25/245) versus 
8.7% (66/755) among those without any travel history 
(p =  0.489). Among those with parasites, 66.7% (66/91) 
did not travel in comparison to 27.3% (25/91) who trav-
elled outside the village. Among the 25 positives who 
travelled outside the village, 44% (11/25) had stayed over-
night in the forest.
Prevalence of parasitaemia was 8.0% (68/849) among 
those who used ITNs every night, 15.2% (20/132) among 
those who sometimes used ITNs, and 15.8% (3/19) 
among those who never used ITNs, p  =  0.004. Para-
site prevalence varied between the strata used for sam-
pling: 19.9% (39/196) among young men, 9.9% (27/272) 
among older men, 4.8% (12/247) among young women, 
and 4.6% (13/285) among older women. Men were more 
likely to use ITNs irregularly or never (27.1%; 127/468) 
Table 2 Univariate associations between factors investigated for prevalence of Plasmodium infection by uPCR
* Pearson Chi Square test
a Mantel Haenszel odds
b Logistic regression, adjustment for gender, age group, temperature ≤ 37.5 °C
Variable Number uPCR positive 
for Plasmodium
uPCR negative 
for Plasmodium
p value* Odds ratioa Adjusted 
odds ratiob
Number (%) Number (%) (95% CI) (95% CI)
Number 1000 91 (9) 909 (91)
Gender <0.0001 3.3
(2.0–5.4)
2.0
(1.2–3.4)
 Male 468 66 (14) 402 (86)
 Female 532 25 (5) 507 (95)
Age groups (years) 0.018 1.6
(1.1–2.6)
2.1
(1.3–3.4)
 18–30 443 51 (11.5) 392 (88.5)
 >30 557 40 (7.2) 517 (92.8) 
Tympanic temperature (°C) 0.365 0.7
(0.3–1.5)
0.9
(0.4–1.9)
 ≤37.5 883 83 (9) 800 (91)
 ≥37.5 117 8 (7) 109 (93)
Self-reported fever in previous 48 h 0.255 0.6
(0.2–1.5)
0.7
(0.3–1.8)
 Fever 87 5 (6) 82 (94)
 No fever 913 86 (9) 827 (91)
Self-reported illness in the previous 
48 h
0.121 0.7
(0.5–1.1)
0.9
(0.6–1.5)
 Illness 506 39 (8) 467 (92)
 No illness 494 52 (11) 442 (89)
Self-reported history of ever having 
had malaria in past
<0.0001 5.3
(2.6–10.9)
5.1
(2.5–10.7)
 Yes 654 82 (13) 572 (87)
 No 346 9 (3) 337 (97)
Forest visit in the previous 3 months <0.0001 4.1
(2.5–6.5)
2.7
(1.6–4.8)
 Yes 156 35 (22) 121 (78)
 No 844 56 (7) 788 (93)
Travel in the previous 3 months 0.489 1.2
(0.7–1.9)
1.1
(0.7–1.8)
 Yes 245 25 (10) 220 (90)
 No 755 66 (9) 689 (91)
Bed net use 0.004 0.5
(0.3–0.8)
0.8
(0.5–1.5)
 Everyday 849 68 (8) 781 (92)
 Sometimes or never 151 23 (15) 128 (85)
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versus women (24.5%; 4/532) p < 0.0001. Men were also 
more likely than women to stay overnight in forests 28.4% 
(133/468) versus 4.3% (23/532), p  <  0.0001. Young men 
(35.2%; 69/196) used ITNs irregularly or never, and 36.7% 
(72/196) had spent a night in a forest within the past 
3 months.
After adjustment, being male (OR 2.0; 95% CI 
1.2–3.5), younger adults (age 18–30; OR 2.1; 95% CI 
1.3–3.4), recent forest travel (OR 2.6; 95% CI 1.5-4.5), 
and a prior history of malaria (OR 5.3; 95% CI 2.6–
11.0) remained significantly associated with parasite 
prevalence.
Parasitaemia was higher among P. falciparum-posi-
tive individuals than those with P. vivax. Parasitaemia 
was lowest among people with undetermined Plasmo-
dium species where the species were not determined. 
Tympanic temperature was not associated with the 
level of parasitaemia for any Plasmodium species 
(Fig. 2).
Sub‑clinical Plasmodium falciparum
Among participants with Plasmodium parasitaemia, 
seven/91 had P. falciparum parasites. Among the seven 
with P. falciparum parasites, ages ranged from 22 to 
49  years. None reported fever within the 48  h before 
screening and none had a temperature  >37.5  °C. All 
reported having clinical malaria in the past, and five 
reported illness in the previous 48  h. Three came from 
one village, ODA, and two from another, Ou Ta Teak 
(OTK). Four had stayed in a local forest overnight in the 
previous 3 months, of whom two reported travel outside 
the village in the same period. Two were positive both 
by RDT and by microscopy. Only one of seven falcipa-
rum positives had a history of travel to another province 
within the previous 3  months. Five reported everyday 
ITN use.
Markers of artemisinin resistance
Six of seven P. falciparum parasite strains detected by 
uPCR could be sequenced for PfKelch 13 mutations. 
All six P. falciparum isolates obtained Pfkelch13 C580Y 
mutation.
Association between sub‑clinical prevalence and clinical 
malaria incidence
Malaria incidence was obtained for 19/20 survey loca-
tions from provincial health department records in 2014 
and 2015. Overall malaria prevalence in the March–
April 2015 survey measured by uPCR significantly cor-
related with the incidence in each of 2014 and 2015 
(p  =  0.003 and p  <  0.001), respectively. Plasmodium 
vivax prevalence correlated with P. vivax incidence 
(p =  0.001 and p =  0.002), respectively. No correlation 
was observed between P. falciparum prevalence and inci-
dence (p = 0.36 and p = 0.59). The combined prevalence 
of P. vivax and undetermined Plasmodium parasites 
(p  <  0.001) was also correlated with P. vivax incidence. 
This was done as previous surveys found approximately 
90% of undetermined Plasmodium species detected by 
uPCR in western Cambodia were later identified as P. 
vivax during 12 months of prospective follow-up (Addi-
tional file 1: Figure S1) [14] (Figs. 3, 4).
Village malaria worker treatment records
Among all clinical malaria cases reported by VMWs, 
154 (12.7%) were among people aged 45  years and 
above, 842 (69.6%) aged 15–45, 189 (15.6%) aged five 
to 15, and (2.1%) aged  <5  years. People recorded as 
migrants (no permanent address in the village) accounted 
for (297/634) 43.9% of all malaria cases in 2013, and 
(201/523) 38.4% in 2014; 914/1,210 (75.5%) of subjects 
were male and 295/1,210 (24.5%) were female. There was 
an approximately three-fold reduction in the number of 
P. falciparum and mixed P. falciparum and P. vivax cases 
from 88 (13.9%) and 237 (37.4%) in 2013, to 36 (7.3%) and 
66 (13.0%) in 2014, respectively. The number and propor-
tion of P. vivax cases increased from 309 (48.7%) in 2013 
to 417 (79.7%) in 2014 respectively (Fig. 5).
Discussion
Spatial heterogeneity and risk factors for parasitaemia
Variations observed in the prevalence of malaria in the 
study villages were consistent with a recent study in the 
northeast of Cambodia, which also found evidence of 
heterogeneity of malaria prevalence in nearby villages.
In the low season nearly one in ten people had malaria 
parasites. Sub-clinical vivax parasitaemia had a higher 
prevalence than sub-clinical falciparum parasitaemia. 
The predominance of P. vivax in the infections detected 
in the survey is consistent with local treatment records. 
Fig. 2 Parasite genome count by Plasmodium species, tympanic 
temperature ≥ 37.5 °C and method of detection
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A significant proportion of clinical falciparum cases were 
among migrants. More detailed information on travel 
history and places of overnight stay in malaria-endemic 
areas would be helpful to better explain where malaria 
infections were acquired.
Young men were at greater risk of clinical malaria and 
had a higher prevalence of sub-microscopic malaria para-
sites compared to older men or to adult women. Young 
men were also more likely to spend time in forests and 
use ITNs irregularly or not at all, consistent with other 
studies in Cambodia [20, 21].
Plasmodium vivax prevalence determined by uPCR 
significantly correlated with vivax malaria incidence 
in each of 2014 and 2015, whereas no relationship was 
observed for P. falciparum. Due to the shorter duration 
of P. falciparum infections, it is unlikely that a single 
snapshot of P. falciparum by uPCR during the dry sea-
son would be able to describe the picture of P. falcipa-
rum infections throughout the whole year. Whereas for 
P. vivax, the higher persistence of sub-clinical infections 
means a survey in the dry season reveals a large reser-
voir of infections. In a previous longitudinal study a large 
proportion of sub-clinical P. vivax persisted through the 
year and seasonality had little effect on the number of 
detectable infections [14]. Even with testing a relatively 
small sample of each village’s population, there was a 
Fig. 3 Plasmodium species prevalence by uPCR in 2015 and incidence of malaria cases in 2014. a Plasmodium falciparum prevalence by uPCR and 
falciparum malaria and mixed malaria incidence 2014; b Plasmodium vivax prevalence by uPCR and vivax malaria incidence 2014; c Plasmodium 
vivax and undetermined Plasmodium species prevalence by uPCR and vivax malaria incidence 2014; d Plasmodium prevalence by uPCR and malaria 
incidence 2014. In each graph, X axis represents Plasmodium prevalence by uPCR during March–April 2015 and Y axis represents malaria cases per 
1000 population in a 1-year period. API annual parasite incidence. API = (confirmed cases during 1 year/population under surveillance) ×1000. In 
2014, *19 out of 20 villages malaria incidence rates were available from Battambang Provincial Health Department and are included in the analyses, 
except MKO
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significant association between numbers with clinical 
and sub-clinical P. vivax.
Implications for vivax treatment
There was a significant association between a prior his-
tory of malaria and having vivax parasitaemia. These self-
reported histories (which often dated back many years) 
are not a promising target to guide screening or treat-
ment as the absolute risk difference was 3% (12 versus 
9% overall) and two-thirds of all participants reported a 
history of clinical malaria. However, clinical treatment 
records of confirmed malaria diagnoses are a more reli-
able predictor of persistent vivax parasitaemia [22].
Implications for falciparum elimination
To accelerate malaria elimination, malaria control pro-
grammes in Cambodia and other countries are evaluating 
various strategies for mass drug administration (MDA) 
[11, 23–25]. Although in the dry season P. falciparum 
prevalence in these villages was very low, six of seven 
uPCR-positive P. falciparum infections did not have 
recent history of travel to another province, suggesting 
some ongoing local transmission. Without the contribu-
tion of migrants to the clinical malaria records Samlout 
District may be close to interruption of P. falciparum 
transmission, but imported cases may undermine elimi-
nation. In a recent study in neighbouring Pailin Province, 
Fig. 4 Plasmodium species prevalence by uPCR and incidence of malaria cases in 2015. a Plasmodium falciparum prevalence by uPCR and falcipa-
rum or mixed malaria incidence 2015; b Plasmodium vivax prevalence by uPCR and vivax Malaria incidence 2015; c Plasmodium vivax and undeter-
mined Plasmodium species prevalence by uPCR and vivax malaria incidence 2015; d Plasmodium prevalence by uPCR and malaria incidence 2015. 
In each graph, X axis represents Plasmodium prevalence by uPCR during March–April 2015 and Y axis represents malaria cases per 1000 population 
in a 1-year period, API annual parasite incidence. API = (confirmed cases during 1 year/population under surveillance) ×1000. In 2015, *19 out of 20 
villages malaria incidence rates were available from Battambang Provincial Health Department and are included in the analyses, except for PEM
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a high proportion of P. falciparum clinical cases were 
found to have C580Y Kelch mutations, and in 2013-14 
prevalence surveys in Pailin, approximately half of all 
asymptomatic P. falciparum infections had markers asso-
ciated with artemisinin resistance [7, 14]. In Laos, a high 
proportion of asymptomatic parasitaemias had the same 
marker associated with artemisinin resistance [26].
Limitations and strengths
The cross-sectional survey design was unable to resolve 
whether past clinical malaria left persistent parasites or 
whether these individuals were parasitaemic because they 
were generally at a higher risk. This study was conducted 
during the dry season and studies from Pailin in 2013–2014 
reported a several-fold variation in P. falciparum preva-
lence over one year; therefore, it is not possible to estimate 
the overall contribution of these infections to transmission 
in these communities. It was also not possible to determine 
the Plasmodium species of some parasitaemias. Gener-
ally these were the participants with the lowest quantity of 
parasite DNA. The incidence data could be incomplete as 
VMW data from 2014 may have missed some people who 
went to other places for diagnosis and treatment.
Conclusions
The low season reservoir consisted chiefly of P. vivax 
infections with very low P. falciparum prevalence. Plas-
modium vivax prevalence correlated with incidence of 
clinical malaria episodes while P. falciparum did not. 
Knowledge of the crude P. falciparum incidence alone 
was not a reliable tool to predict the hidden parasite 
reservoir during the dry season in this instance. More 
detailed knowledge of the characteristics of the P. falci-
parum cases, such as occupation and travel history could 
potentially distinguish indigenous and imported malaria 
and thereby improve the use of local treatment records to 
predict the sub-clinical P. falciparum reservoir. This can 
be a particularly useful tool to target malaria elimination 
activities such as mass screening and treatment or mass 
anti-malarial drug administration.
Much clinical P. falciparum was among migrants, forest 
workers or those recently returned from other provinces, 
suggesting transmission inside the villages themselves is 
now very low. Young men were more likely to have sub-
microscopic malaria than older men or females of any 
age and to exhibit behaviour that exposes them to the 
risk of infection (and transmission). Imported malaria 
has the potential to undermine provincial P. falciparum 
elimination efforts as clinical and sub-clinical infections 
are brought into the district by migrant workers and by 
local people returning from other provinces.
The spatial heterogeneity of Plasmodium prevalence 
between neighbouring villages shows that there is impor-
tant variability in malaria epidemiology at a local level. 
Knowledge of the recent, detailed travel history of clini-
cal malaria cases could provide crucial information about 
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the probable source of infection and could help deter-
mine the risk of infection within individual villages. Even 
in villages with indigenous transmission, strategies to 
screen or treat sub-microscopic malaria in the dry sea-
son may be undermined by subsequent immigration of 
parasitaemic individuals. Therefore, targeting high-risk 
groups, e.g., migrant labourers, forest goers, by offering 
free screening and treatment, may prevent re-importa-
tion of malaria parasites from areas of higher transmis-
sion to areas in pre-elimination state and this could be an 
effective tool to eliminate falciparum malaria. Simultane-
ously, mass treatment in high transmission areas around 
the start of the malaria transmission season at commu-
nity level may reduce the incidence of falciparum malaria 
significantly. It could have a collateral effect on a whole 
geographical area moving towards malaria elimination.
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